The start of a Phase 2 trial is a key step for Oncolytics Biotech (Oncolytics Biotech Stock Quote, C... Read More
Alberta-based biologics developer Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TS... Read More
Compared to its oncology drug peers, Canadian cancer biologics developer Oncolytics Biotech (Oncolyt... Read More
Echelon Wealth Partners analyst Douglas Loe says price softness in cancer biologics developer Oncoly... Read More
Echelon Wealth Partners analyst Doug Loe thinks cancer biologics company Oncolytics Biotech (Oncolyt... Read More
Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart TSX:ONC) announced its third quarter finan... Read More
Share
